Generex Announces U.S. Congressman Curt Weldon, Co-Founder of the ...
, The United States Armed Services, and the global healthcare sector. Congressman Weldon will also provide advice and assistance to the Company in its relationships with governments and governmental agencies.Congressman Weldon served in the US Congress for 20 years (1987-2007) and retired as Vice Chair of the Military Oversight Committee (HASC) as well as Vice Chair of the Homeland Security Committee. During his tenure, Weldon also served as a senior Member of the Science Committee and Chair of the Defense Research Committee where he provided oversight for all funding for the National Institutes of Health (NIH), the National Science Foundation (NSF) as well as all Military Medical Research Funding. Weldon also founded and Chaired the 4 State SMART Research Initiative. Weldon founded and Co-Chaired the Congressional Diabetes Caucus. He has keynoted multiple national Diabetes Group Conferences, won several National Diabetes Awards and is married to and a Certified Diabetes Educator.
During his 20 year tenure in Congress, Weldon founded and Co-Chaired bi-lateral Parliamentary Relationships with 12 countries and led bipartisan Congressional Delegation trips to over 100 nations worldwide. Weldon maintains high-level personal international business and government relationships and sits on the Boards of two international Nobel Oil Corporation Boards. He has led business delegations to over 40 nations since leaving Congress and continues to provide high level speeches such as the FOFM 2011 (Future of Financial Markets) Keynote Speech in for Life' disaster coordination and planning initiative.
Prior to his tenure in Congress, Weldon served as an educator/professor and worked as a Director in the Corporate HQ of the INA/CIGNA Corporation.
"We are delighted that Congressman Weldon has agreed to provide Generex with access to his vast global network of relationships, and to apply his expansive experience and expertise to the benefit of Generex," commented , Generex President & Chief Executive Officer. Congressman Weldon stated: "I am impressed by the new management team at Generex and the strategic development plan for the Company they have begun to implement. I look forward to assisting Generex management in their efforts to create value for the Company's stockholders."
About Generex Biotechnology Corporation
Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T helper stimulation in immunotherapy. One of its platform technologies relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T helper cells and prevents the further growth of cancer cells. For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com .
Clinical Trials In Asia - News
The purpose of the Phase II clinical trial is to determine the dosage level through evaluating the immunogenicity and safety with different level of dosages of Sinovac's EV71 vaccine candidate, and to provide the reference data for Phase III clinical
Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials. Because of this, statements regarding the expected timing of clinical trials
In 2004, Iacocca launched Join Lee Now, a national grassroots campaign that brought Faustman's research to human clinical trials. In 2000, Iacocca founded Olivio Premium Products, which donates all profits from the company to diabetes research.
Almac has set up new depots for clinical trial materials in Asia-Pacific as part of a plan to build its presence in a one of the world's fastest growing markets. The Northern Ireland-headquartered Almac has added depots in Japan, Thailand, Hong Kong,
Previous trials and clinical reports conducted in Asia have already evidenced NeuroAiD's safety and efficacy in post stroke rehabilitation, even when taken several months after the stroke's onset. This paper comes after the publication of three
Growth Hormone Deficiency Global Clinical Trials Review, Q2 ...
GlobalData's clinical trial report, "Growth Hormone Deficiency Global Clinical Trials Review, Q2, 2011" provides data on the Growth Hormone Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Growth Hormone Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Growth Hormone Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Clinical Trials In Asia - Bookshelf
Clinical research law and compliance handbook
In a study entitled The Globalization of Clinical Trials: A Growing Challenge in ... deficiencies in the ethical review systems for clinical trials in Asia, ...Clinical trials of drugs and biopharmaceuticals
In Asia, diseases such as hepatitis C, severe acute respiratory syndrome (SARS), ... drug companies to conduct clinical trials in Asia for these diseases. ...International Management, Strategy and Culture in the Emerging World
But they will have to set aside these concerns in doing basic research in Asia and following up with clinical trials in several Asian countries to be able ...AIDS in Asia, the challenge ahead
Mechanisms of retention of volunteers in clinical trials in particular phase-II and efficacy trials will be key factors for success. ...Clinical and Translational Science, Principles of Human Research
The University of Auckland hosts a Clinical Trials Research Unit active both in ... Scientific programs in Asia, Africa and South/Central America and the ...Daily Information Directory
IQPC Clinical Trial Supply Asia
Clinical Trial Supply Asia 2011 is the LEADING CONFERENCE GLOBALLY that will focus on clinical trial supply issues and challenges in Asia! Don't miss it! ...
IQPC Clinical Trials in Oncology Asia
Clinical Trials in Oncology Asia, iqpc ... 1 expert-led workshop will provide you with strategies of deciding the endpoints of trials on typical cancer types in Asia ...
Clinical Partnerships Asia Pacific Welcome
IIR presents Partnerships in Clinical Trials Asia Pacific December 1-3, 2009 in Singapore at the InterContinental
Clinical Trials - Editorial Sections - Pharma Focus Asia
List of all Clinical Trials Companies profiles. ... The Asia Pacific region has seen spectacular growth in large-scale clinical trials in recent years. ...
Emerging Markets Clinical Trials: Asia
As more companies move clinical trials into this region, they will ... The three chapters in Emerging Markets Clinical Development Series: Asia use primary and ...